Table of Contents
Definition and Background
Spleen: The spleen is a firm abdominal organ, dull red in color, that lies under the diaphragm on the left side. It measures 1 X 3 X 5 inches, weighs approximately 7 oz and lies between the 9th and 11th ribs, hence summarized by the odd numbers 1, 3, 5, 7, 9, and 11.
The spleen consists of the two formations: the red pulp and the white pulp that are covered by a dense fibrous covering called the splenic capsule. The red pulp filters damaged red blood cells, hosts macrophages and platelets, and release them into the bloodstream when needed. The white pulp is the place where white cells grow and mature (extramedullary hemopoiesis).
The spleen is not a vital organ. Though spleen is the largest lymphoid organ and has a variety of functions, including immunosurveillance and hematopoiesis, the body can manage without the spleen when it is removed due to particular reasons (injury, blood diseases).
Splenomegaly: Splenomegaly is the enlargement of the spleen. The normal spleen is usually not palpable on abdominal examination, except in adolescents and thin slender build individuals. The splenomegaly is classically a clinical sign, but with technological advancements, even mild splenomegaly is detected on the imaging studies. Usually, when the spleen is palpable, it is often enlarged two-to-three times than the normal size.
Hypersplenism: Hypersplenism means increased functioning of the spleen, while splenomegaly simply denotes an increased size of the spleen. It is not necessary that all the enlarged spleens are hyperfunctioning. The four cardinal features of hypersplenism are:
- Anemia, leukopenia, thrombocytopenia and/or pancytopenia
- Bone marrow hyperplasia (compensatory)
- Improvement after splenectomy
Etiology of Splenomegaly
The common causes of splenomegaly are:
- Hematological: The hematological disorders are one of the common causes of splenomegaly that include chronic myeloid leukemia (CML), chronic lymphocytic leukemia (CLL), acute leukemias, lymphomas, primary myelofibrosis, polycythemia vera, hairy cell leukemia, thalassemia, and different anemias.
- Liver disease and portal hypertension: Hepatic cirrhosis, portal or splenic vein thrombosis.
- Storage diseases: Gaucher’s disease, Niemann–Pick disease.
- Systemic diseases: Sarcoidosis, amyloidosis, and collagen diseases – systemic lupus erythematosus, rheumatoid arthritis, Felty syndrome.
- Infections: Malaria, leishmaniasis, schistosomiasis, severe septicemia, bacterial endocarditis, typhoid, AIDS, hydatid disease, abscesses, and infectious mononucleosis.
- Splenic metastasis, cysts, and hemangiomas.
- Systemic mastocytosis
- Histiocytosis X
Epidemiology of Splenomegaly
Splenomegaly is a common finding and is reported in 2% to 5.6% of patients in the United States. There is no racial predilection but certain causes are more frequent in certain races such as sickle cell anemia in Blacks and certain lysosomal storage diseases in Ashkenazi Jews.
Some causes of splenomegaly have geographical predilection such as tropical splenomegaly syndrome (or hyperactive malarial syndrome), which is common in tropics where malaria is endemic. Tropical splenomegaly syndrome is twice more common in females. The acute leukemias and storage disorders are common in the children and adolescents, while the chronic leukemias are common in the older population.
Clinical Presentation of Splenomegaly
The clinical presentation of patients with splenomegaly depends upon the underlying etiology, for example, malaria presents with high-grade fever, chills, rigors, and sweating. The leukemias present with features of pancytopenia, and cirrhotic patients may present with abdominal distension, ascites, hematemesis and/or hepatic encephalopathy.
The splenomegaly itself is often asymptomatic and detected incidentally. When severely enlarged, it may cause abdominal distension, dull abdominal pain, and early satiety.
It is important to review the family history to identify relevant hereditary diseases, such as hemolytic anemias, and lysosomal storage diseases.
Diagnosis of Splenomegaly
Splenomegaly is a clinical sign rather than a full diagnosis. It is associated with a long list of causes (as described above). When splenomegaly is present, the patients should be properly evaluated to identify the etiologic cause, and in most cases, the causes are infections, portal hypertension, neoplasms, or autoimmune disorders.
- Complete blood counts with peripheral thick and thin films (for malaria)
- Liver function tests and viral hepatitis profile
- Autoimmune screen and inflammatory markers
- Cytogenetic tests (BCR-ABL, tyrosine kinase)
- Ultrasound examination of the abdomen
- CT scan of the abdomen
- Bone marrow aspirate
- Lymph node biopsy
- Full liver screen
Grading of Splenomegaly
The splenomegaly has been graded from grade 0 to 5 according to the Hackett ’ s grading system, which is as follows:
- Grade 0: Normal impalpable spleen.
- Grade 1: Spleen palpable only on deep inspiration
- Grade 2: Spleen palpable on mid-clavicular line, half way between umbilicus and costal margin
- Grade 3: The spleen expands towards the umbilicus
- Grade 4: The spleen goes past the umbilicus
- Grade 5: The spleen expands towards the pubis symphysis.
Differential Diagnosis of Splenomegaly
The differential diagnosis of splenomegaly is huge. It often can be shortlisted depending upon the splenic size and other clinical features.
The massive splenomegaly is when the spleen is palpable >8cm below the left costal margin with the maximum cephalocaudal diameter of spleen being >20cm. The common causes associated with massive splenomegaly are:
- Chronic Myeloid lymphoma (CML)
- Primary myelofibrosis
- Thalassaemia major or intermedia
- Gaucher’s disease
Moderate splenomegaly is when the spleen is palpable 5-8 cm below left costal margin with the maximum cephalocaudal splenic diameter being 11-20cm.
Mild splenomegaly is when the spleen is palpable <5cm below the left costal margin and maximum cephalocaudal splenic diameter is <10 cm.
The causes of mild and moderate splenomegaly are as follows:
- Congestive heart failure
- Liver cirrhosis and portal hypertension
- Severe bacterial sepsis
- Infective endocarditis
- Sickle cell anemia
- Acute infectious illnesses (typhoid, malaria, other tropical diseases)
- Acute viral infections (infectious mononucleosis)
- Systemic lupus erythematosus
- Tuberculosis (chronic forms)
- Idiopathic splenomegaly
- Immune hemolytic anemia
- Immune thrombocytopenic disorders
Management of Splenomegaly
The conservative management of splenomegaly depends upon the underlying disorder and patient’s clinical status. E,g, malaria is treated with antimalarials, infections with antibiotics and leukemias with chemotherapeutic agents. The splenomegaly often resolves when the underlying cause is appropriately managed. The additional supportive measures may include blood transfusions/exchange transfusions and prophylactic antibiotics.
Low-dose radiotherapy has been used as palliative care in patients with advanced hematological problems (primary myelofibrosis).
Splenectomy is the surgical removal of the spleen. It is required in certain cases when splenomegaly becomes a reason of the aggravation of the basic condition.
Indications for splenectomy:
- Hemolytic anemias (some cases), e.g. hereditary spherocytosis, autoimmune hemolytic anemia, thalassemia major or intermedia
- Chronic lymphocytic leukemia and lymphomas
- Chronic immune thrombocytopenia
- Primary myelofibrosis
- Tropical splenomegaly
- Splenic trauma and rupture
Recommendations for vaccination of patients before splenectomy
Pneumococcal polyvalent vaccine, Hemophilus influenzae type b and meningococcal conjugate vaccines are recommended two weeks before elective splenectomy. In cases of urgent splenectomy after trauma or splenic rupture, the vaccines should be given two weeks after urgent splenectomy.
Influenza vaccine is recommended annually.
The correct answers can be found below the references.
1. A 27-year-old unconscious man was brought to ER after an RTA. On exam, a palpable mass is present in left hypochondrium. CBC reveals pancytopenia, hematocrit of 23% (Normal 40-54%). A helical CT scan detected an intra-parenchymal blush in the spleen area.
What is the most probable diagnosis? What is the most appropriate management for the condition?
- Spleen rupture/Splenectomy
- Spleen rupture/Fluid infusion
2. A 20-year-old male presents with history of weight loss, fatigue, yellow discoloration of the skin, poor appetite, and dizziness. On exam, his hands and feet are swollen. Multiple bruise marks are present all over the body. CBC reveals hemoglobin S. What is the most probable primary diagnosis? What imaging findings would follow this condition?
- Sickle cell anemia/hepatosplenomegaly
- Hemolytic anemia/hepatosplenomegaly
- Hodgkin`s lymphoma/hepatosplenomegaly
- Non-Hodgkin`s lymphoma/hepatosplenomegaly
3. A 58-year-old male patient complains of vomiting, nausea, weight loss, abdominal pain and “heaviness” in the right side of the abdomen. He is chronic alcoholic. His brother suffers from hemolytic anemia. On physical examination, there are obvious signs of cirrhosis, namely caput medusa, ascites, jaundice, telangiectasias; and heart murmur. A CT reveals an enlarged spleen. What is the most probable reason for the spleen enlargement, and what scale of the enlargement would be found in this patient?
- Splenic vein obstruction due to cirrhosis/moderate splenomegaly
- Splenic vein obstruction due to cirrhosis/massive splenomegaly
- Portal vein obstruction/moderate splenomegaly
- Portal vein obstruction/moderate splenomegaly